EICHORPublic-registry site landscape for NCT05789537, “A Study of SerpinPC in Participants with Hemophilia B (HemB) with Inhibitors”, a Hemophilia B with Inhibitor study sponsored by ApcinteX Ltd. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05789537 (registry record) |
| Study title | A Study of SerpinPC in Participants with Hemophilia B (HemB) with Inhibitors |
| Official title | A Global, Open-label Study to Investigate the Efficacy and Safety of SerpinPC in Subjects with Hemophilia B with Inhibitors |
| Sponsor | ApcinteX Ltd |
| Condition(s) | Hemophilia B with Inhibitor; Hemophilia B |
| Phase | PHASE2 |
| Listed sites | 20 |
| Site countries | United States, Armenia, Australia, France, Germany, India, Italy, Spain, Taiwan, Turkey (Türkiye), United Kingdom |
Patient-friendly overview of this study: eichor.com/study/NCT05789537.
Eichor generates a preliminary site-risk snapshot for NCT05789537 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Other Hemophilia B with Inhibitor trials
← Eichor home · All tracked trials · Hemophilia B with Inhibitor studies · Weekly briefs
